Overview
BDSX market data
Price History
BDSX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$4.67 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.57 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $5.26 – $24.92 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $226.5 · P/B 10.66 · P/S 2.36.
Company news
Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026Globenewswire Inc · Jul 22, 2026, 11:00 AM
Roth Capital Initiates Coverage On Biodesix with Buy Rating, Announces Price Target of $32Benzinga · Jun 25, 2026, 11:05 AM
Canaccord Genuity Maintains Buy on Biodesix, Raises Price Target to $27Benzinga · Jun 18, 2026, 1:20 PM
This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayBenzinga · Jun 15, 2026, 1:20 PM
Biodesix to Participate in Upcoming Investor ConferencesGlobenewswire Inc · May 21, 2026, 11:15 AM
8-K filing — BIODESIX INC (BDSX)SEC EDGAR · May 4, 2026, 8:03 PM